DNLI

15.36

5.65% -0.92

Vorhandelsmarkt: 15.22 -0.14 -0.91%

Denali Therapeutics Inc (DNLI)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt DNLI? Forum Prognose

Schlusskurs vom Vortag:

$16.28

Offen:

$15.98

24-Stunden-Volumen:

1.54M

Relative Volume:

0.80

Marktkapitalisierung:

$2.25B

Einnahmen:

$340.81M

Nettoeinkommen (Verlust:

$-419.65M

KGV:

-5.3895

EPS:

-2.85

Netto-Cashflow:

$-402.10M

1W Leistung:

-5.24%

1M Leistung:

-0.39%

6M Leistung:

-6.57%

1J Leistung:

-43.22%

1-Tages-Spanne:

$15.00

$16.33

1-Wochen-Bereich:

$15.00

$17.02

52-Wochen-Spanne:

$10.57

$33.33

Denali Therapeutics Inc Stock (DNLI) Company Profile

Firmenname

Denali Therapeutics Inc

Sektor

Healthcare (1136)

Branche

Biotechnology (633)

Telefon

(650) 866-8547

Adresse

161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO

Mitarbeiter

486

Twitter

Nächster Verdiensttermin

2025-08-08

Neueste SEC-Einreichungen

DNLI's Discussions on Twitter

Vergleichen Sie DNLI mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
DNLI Denali Therapeutics Inc	15.36	2.38B	340.81M	-419.65M	-402.10M	-2.85
VRTX Vertex Pharmaceuticals Inc	426.00	109.11B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	642.25	68.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	434.07	60.25B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	826.28	50.39B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	186.23	40.44B	447.02M	-1.18B	-868.57M	-6.1812

Denali Therapeutics Inc Stock (DNLI) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-04-10	Hochstufung	Cantor Fitzgerald	Neutral → Overweight
2025-03-07	Fortgesetzt	Morgan Stanley	Overweight
2025-02-11	Eingeleitet	Deutsche Bank	Buy
2025-01-07	Eingeleitet	Robert W. Baird	Outperform
2025-01-03	Eingeleitet	William Blair	Outperform
2024-12-16	Hochstufung	Stifel	Hold → Buy
2024-10-10	Fortgesetzt	Raymond James	Mkt Perform
2024-10-07	Herabstufung	Cantor Fitzgerald	Overweight → Neutral
2023-12-13	Eingeleitet	Citigroup	Buy
2023-11-20	Fortgesetzt	JP Morgan	Overweight
2023-10-24	Fortgesetzt	Cantor Fitzgerald	Overweight
2023-09-06	Eingeleitet	B. Riley Securities	Buy
2023-01-30	Eingeleitet	SVB Securities	Outperform
2022-12-05	Eingeleitet	Cowen	Outperform
2022-11-02	Hochstufung	BTIG Research	Neutral → Buy
2022-11-02	Eingeleitet	BofA Securities	Buy
2022-06-23	Eingeleitet	Berenberg	Buy
2021-12-10	Fortgesetzt	Raymond James	Mkt Perform
2021-09-21	Eingeleitet	Oppenheimer	Outperform
2021-09-01	Eingeleitet	SMBC Nikko	Outperform
2021-05-18	Eingeleitet	UBS	Buy
2021-02-26	Bestätigt	H.C. Wainwright	Buy
2021-02-10	Hochstufung	Cantor Fitzgerald	Neutral → Overweight
2020-11-11	Bestätigt	H.C. Wainwright	Buy
2020-10-16	Herabstufung	BTIG Research	Buy → Neutral
2020-09-14	Fortgesetzt	JP Morgan	Overweight
2020-08-20	Bestätigt	H.C. Wainwright	Buy
2020-03-13	Hochstufung	Evercore ISI	In-line → Outperform
2020-02-28	Hochstufung	Wedbush	Neutral → Outperform
2020-02-24	Eingeleitet	Jefferies	Buy
2020-02-19	Eingeleitet	Stifel	Hold
2020-01-27	Hochstufung	Goldman	Neutral → Buy
2019-09-26	Eingeleitet	Wedbush	Neutral
2019-09-13	Eingeleitet	Nomura	Buy
2019-08-09	Eingeleitet	BTIG Research	Buy
2019-06-26	Eingeleitet	H.C. Wainwright	Buy
2018-11-15	Eingeleitet	Cantor Fitzgerald	Overweight
2018-11-12	Eingeleitet	Janney	Buy
2018-03-12	Herabstufung	Evercore ISI	Outperform → In-line
2018-01-02	Eingeleitet	Evercore ISI	Outperform
2018-01-02	Eingeleitet	Goldman	Neutral
2018-01-02	Eingeleitet	JP Morgan	Overweight
2018-01-02	Eingeleitet	Morgan Stanley	Overweight

Alle ansehen

Denali Therapeutics Inc Aktie (DNLI) Neueste Nachrichten

Nov 03, 2025

Can Denali Therapeutics Inc. (4DN) stock test all time highs2025 EndofYear Setup & Safe Capital Investment Plans - newser.com

Nov 03, 2025

Will Denali Therapeutics Inc. (4DN) stock outperform small cap peersMarket Performance Report & High Accuracy Investment Signals - newser.com

Nov 03, 2025

Why analysts remain bullish on Denali Therapeutics Inc. stockJuly 2025 Highlights & AI Forecast Swing Trade Picks - newser.com

Nov 03, 2025

Is Denali Therapeutics Inc. stock a top momentum play2025 Geopolitical Influence & Real-Time Chart Pattern Alerts - newser.com

Nov 03, 2025

Why Denali Therapeutics Inc. stock is favored by pension fundsWeekly Trend Summary & High Return Trade Opportunity Guides - newser.com

Nov 03, 2025

Will Denali Therapeutics Inc. stock outperform Nasdaq index2025 Macro Impact & Free Daily Entry Point Trade Alerts - newser.com

Nov 03, 2025

Is Denali Therapeutics Inc. stock a dividend growth opportunityWeekly Stock Recap & Daily Profit Maximizing Tips - newser.com

Nov 03, 2025

Comparing Denali Therapeutics Inc. in custom built stock radars2025 Short Interest & Fast Moving Trade Plans - newser.com

Nov 03, 2025

Is Denali Therapeutics Inc. stock supported by strong cash flows2025 AllTime Highs & High Accuracy Swing Trade Signals - newser.com

Nov 03, 2025

Nov 02, 2025

Is Denali Therapeutics Inc. stock ready for a breakoutAnalyst Downgrade & Risk Managed Investment Signals - newser.com

Nov 02, 2025

Is Denali Therapeutics Inc. stock a contrarian buy2025 Price Action Summary & Momentum Based Trading Ideas - newser.com

Nov 02, 2025

Can Denali Therapeutics Inc. (4DN) stock resist broad market declinesJuly 2025 EndofMonth & Fast Momentum Entry Tips - newser.com

Nov 02, 2025

Will Denali Therapeutics Inc. stock rally after Fed decisionsJuly 2025 Snapshot & AI Enhanced Market Trend Forecasts - newser.com

Nov 02, 2025

Will Denali Therapeutics Inc. (4DN) stock enhance shareholder valueSell Signal & Weekly Return Optimization Alerts - newser.com

Nov 02, 2025

Pier Capital LLC Sells 20,708 Shares of Denali Therapeutics Inc. $DNLI - MarketBeat

Nov 02, 2025